JBS and Indonesia's sovereign fund form $5B protein joint venture

What's the deal? JBSDealroom has a profile for this one. Try Dealroom → on August 7, 2026, announced a partnership with Indonesia's sovereign wealth fund to expand its protein business across Southeast Asia, Australia, and New Zealand. The fund's investment arm, PT Danantara Investment Management (DIM)Dealroom has a profile for this one. Try Dealroom →, will make an initial $2.5 billion contribution to a joint venture combining JBS's Australian and New Zealand assets.

The numbers: With that capital and up to $2.5 billion in debt financing, the new company can deploy as much as $5 billion in investments. DIM will hold 25% of the venture once contributions are complete, while JBS keeps control.

What's the endgame? The funds will build new plants, expand existing operations, and finance acquisitions in the protein sector. For the first two years, investment will target Indonesia exclusively; afterwards, the venture can back projects in other Southeast Asian markets, Australia, and New Zealand.

Why now? The move deepens JBS's footprint in Southeast Asia, a fast-growing protein market, while pairing the world's largest meat company with state capital from Jakarta. Both sides expect an initial public offering of the joint venture after five years.

What could go wrong? The deal still needs regulatory approvals and must meet conditions set out in the agreement before it closes.

The signal: Sovereign wealth funds are increasingly co-investing with global operators to secure food supply and industrial capacity. For JBS, the tie-up spreads risk, brings in local backing, and sets up a possible listing to unlock value in a region central to future protein demand.

Read more: Exame

Image credit: JBS